America warned it is becoming dangerously reliant on China for new medicines
The Trump administration is considering allowing U.S. pharmaceutical companies to continue striking most licensing deals with Chinese drugmakers despite its broader crackdown on investment in China, according to people briefed on the plans.










/file/attachments/orphans/kevin_Minister_128853.jpg)